ONCOLOGY
Drug Discovery
Our team of experts works tirelessly to discover new and innovative drugs that target a variety of Oncology Indications. We use state-of-the-art technology and cutting-edge research techniques to develop drugs that have the potential to change lives.
Our therapeutic areas of focus
At Dozo, we’ve taken major steps over the past decade to address different types of cancers and improve the standards of care.
We are focusing on the cancer types where we can further develop our leadership: Triple Negative Breast cancer, across hormonal subtypes; genitourinary cancer, including prostate and bladder cancer; hematologic malignancies, including multiple myeloma and lymphomas, such as Hodgkin’s disease; and thoracic cancers, which includes lung cancer, Pancreatic Cancer.
Within our tumor areas, we are seeking to deepen our ability to address unmet medical needs across the care continuum – by reaching new and larger patient populations, extending survival and improving quality of life.